We provide solutions in five core areas ensuring success throughout the product lifecycle


Orphan Drug PRMA Strategy:

We recommend the optimal price and access strategy with your unique situation in mind

Environmental analysis:

  • Competitor environment
  • Reimbursement pathways
  • Policy surveillance
  • Stakeholder engagement

Value communications:

  • Global value dossiers
  • Value message testing

Price optimization
Launch Sequence
Public affairs strategy

Evidence Mitigation Solutions

We identify potential gaps in your evidence plans and design solutions to mitigate challenges

  • Identify gaps in clinical / economic data
  • Value messaging
  • Strategy workshops
  • Publication plan for clinical and health economic data

Bespoke Access Roadmaps

We design customized access roadmaps to give you the most pragmatic and effective route to market

Environment Analysis

  • Policy surveillance
  • Reimbursement pathways
  • Procurement
  • Stakeholder group & influencer identification

Competitor tracking

Public affairs strategy

Rare Disease Foresights

We help you learn, and act upon, the latest policy changes, stakeholder and competitor activity

  • Disease area burden
  • Competitor Landscape
  • Health Policy assessment
  • Predictive trend analysis

Access Centre of Excellence

We help you get the most from your market access team and individuals

Expert training workshops on:

  • What is Market Access?
  • Managed entry programs including patient access schemes
  • Tender training
  • Negotiation strategy
  • Business case development
  • Strategy workshop